Leading CAR-T Therapy Companies in APAC
Australia
- Carina Biotech
- Cartherics
- Chimeric Therapeutics
- HaemaLogiX
- Prescient Therapeutics
China
- Legend Biotech
- JW Therapeutics
- Gracell Biotechnologies
- Fosun Kite Biotechnology
- CARsgen Therapeutics
- Chongqing Precision Biotech
- Beike Cell Therapy
- CANbridge Pharmaceuticals
Speaking at Cell & Gene Therapy World Asia (CGTWA) 2025
Deborah Rathjen
Chief Executive Officer, Carina Biotech, Australia
Ian Nisbet
Chief Operating Officer, Cartherics, Australia
Rebecca McQualter
Chief Executive Officer, Chimeric Therapeutics, Australia
Rosanne Dunn
Director & Chief Scientific Officer, HaemaLogiX, Australia
Hong Kong
- ArbeleBio
India
- ImmunoACT
- Cellogen Therapeutics
- Immuneel Therapeutics
Japan
- Takeda Pharmaceutical
- Kyowa Kirin
- BrightPath Biotherapeutics
- Kyoto University (CiRA) & Takeda Pharmaceutical
- Shinshu University & Kyoto Prefectural University of Medicine
Singapore
- Lion TCR
- CytoMed Therapeutics
- Medisix Therapeutics
- Biosyngen
Speaking at Cell & Gene Therapy World Asia (CGTWA) 2025
Lu-En Wai
Senior Director of Research & Development, Lion TCR, Singapore
Andrew Bruce
Chief Executive Officer, Medisix Therapeutics, Singapore
Jean-Paul Thiery
Chief Scientist, BioSyngen, Singapore
South Korea
- GC Cell (Green Cross Cell)
- AbClon
- Helixmith
- Curocell
- TiCARos
- Cartexell
- ViGenCell
Taiwan
- TaiGen Biotechnology
- BioGend Therapeutics
- GenomeFrontier Therapeutics
- ARCE Therapeutics
- UWELL BioPharma
Thailand
- Cellmidi
Share With Your Network
